Piper Sandler Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Piper Sandler analyst Adam Maeder maintained a Buy rating on Intuitive Surgical (ISRG – Research Report) today and set a price target of $435.00. The company’s shares closed yesterday at $372.63.

According to TipRanks, Maeder is a 5-star analyst with an average return of 19.6% and a 59.24% success rate. Maeder covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Shockwave Medical, and Nyxoah.

Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $423.00, a 13.52% upside from current levels. In a report released today, BTIG also maintained a Buy rating on the stock with a $421.00 price target.

ISRG market cap is currently $132.1B and has a P/E ratio of 67.25.

Based on the recent corporate insider activity of 85 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical (ISRG) Company Description:

Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.